ArriVent BioPharma Inc.
AVBP
Market Cap$915.55M
Close$
$2.36
89.2% downside
Current Fair Value
89.2% downsideOvervalued by 89.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $915.55 Million |
|---|---|
| Enterprise Value | $870.19 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.07 |
| Beta | 0 |
| Outstanding Shares | 33,509,090 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.2 |
|---|---|
| PEG | -4.52 |
| Price to Sales | - |
| Price to Book Ratio | 3.63 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.82 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data